Figure 1. The formation of a virus-like particle (VLP). Image Credit: Sino Biological Inc. To enable targeted drug research, Sino Biological has created a VLP protein platform based on the HEK293 ...

In the Virus-Like Particle Translational Oncology Laboratory ... In preclinical studies, VLPs formed by structural proteins are highly immunogenic and capable of inducing protective immunity against ...

The team used a sophisticated approach to breaking down and rebuilding the virus’s protein ... like both a cement and a spacer, contributing to the overall flexibility of the viral particle.

For all the mysteries that remain about the novel coronavirus and the COVID-19 disease it causes, scientists have generated an incredible amount of fine-grained knowledge in a surprisingly short time.

The virus particle comes apart, releasing the viral genome. The viral RNA (vRNA) is translated into a single polypeptide that is cut into ten proteins ... other cells. Like other viruses, the ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

The development of vaccines against NiV is a priority, with various approaches under investigation, including virus-like particle-based and mRNA-based vaccines. However, no vaccine is yet approved ...